Marinus Pharmaceuticals Inc (MRNS)
1.30
-0.03
(-2.26%)
USD |
NASDAQ |
May 16, 16:00
1.33
+0.03
(+2.31%)
Pre-Market: 09:11
Marinus Pharmaceuticals Cash from Operations (Quarterly): -37.46M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -37.46M |
| December 31, 2023 | -26.99M |
| September 30, 2023 | -25.17M |
| June 30, 2023 | -24.36M |
| March 31, 2023 | -41.48M |
| December 31, 2022 | -21.91M |
| September 30, 2022 | -29.64M |
| June 30, 2022 | -33.67M |
| March 31, 2022 | -27.66M |
| December 31, 2021 | -21.75M |
| September 30, 2021 | 5.403M |
| June 30, 2021 | -22.96M |
| March 31, 2021 | -16.18M |
| December 31, 2020 | -16.40M |
| September 30, 2020 | -14.47M |
| June 30, 2020 | -16.01M |
| March 31, 2020 | -14.04M |
| December 31, 2019 | -16.25M |
| September 30, 2019 | -12.00M |
| June 30, 2019 | -8.716M |
| March 31, 2019 | -11.66M |
| December 31, 2018 | -9.158M |
| September 30, 2018 | -6.807M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.728M |
| March 31, 2018 | -6.149M |
| December 31, 2017 | -4.48M |
| September 30, 2017 | -3.123M |
| June 30, 2017 | -4.364M |
| March 31, 2017 | -6.849M |
| December 31, 2016 | -6.048M |
| September 30, 2016 | -6.459M |
| June 30, 2016 | -6.18M |
| March 31, 2016 | -6.082M |
| December 31, 2015 | -5.049M |
| September 30, 2015 | -5.902M |
| June 30, 2015 | -5.226M |
| March 31, 2015 | -3.952M |
| December 31, 2014 | -1.968M |
| September 30, 2014 | -3.107M |
| June 30, 2014 | -2.389M |
| March 31, 2014 | -1.125M |
| December 31, 2013 | -3.126M |
| September 30, 2013 | -1.201M |
| June 30, 2013 | -1.601M |
| March 31, 2013 | -0.699M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-41.48M
Minimum
Mar 2023
5.403M
Maximum
Sep 2021
-21.09M
Average
-21.83M
Median
Cash from Operations (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 18.73M |
| Soligenix Inc | -1.342M |
| Actinium Pharmaceuticals Inc | -7.374M |
| Macrogenics Inc | -45.64M |
| ADMA Biologics Inc | -2.218M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 20.88M |
| Cash from Financing (Quarterly) | 0.257M |
| Free Cash Flow | -113.98M |
| Free Cash Flow Per Share (Quarterly) | -0.6589 |
| Free Cash Flow to Equity (Quarterly) | -37.96M |
| Free Cash Flow Yield | -159.4% |